These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27974462)

  • 1. Down-regulation of microRNA-451a facilitates the activation and proliferation of CD4
    Zeng Z; Wang K; Li Y; Xia N; Nie S; Lv B; Zhang M; Tu X; Li Q; Tang T; Cheng X
    J Biol Chem; 2017 Apr; 292(14):6004-6013. PubMed ID: 27974462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming orchestrates CD4
    Wu J; Sun P; Chen Q; Sun Y; Shi M; Mang G; Yu S; Zheng Y; Li Z; Sun M; Fang S; Zhang Y; Tian J; Mingyan E; Zhang M; Yu B
    J Mol Cell Cardiol; 2019 Oct; 135():134-148. PubMed ID: 31398346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma.
    Wang T; Zhou Q; Shang Y
    J Innate Immun; 2021; 13(1):38-48. PubMed ID: 33271553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
    Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
    Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.
    Chang C; Liu J; He W; Qu M; Huang X; Deng Y; Shen L; Zhao X; Guo H; Jiang J; Fu XY; Huang R; Zhang D; Yan J
    Oncogene; 2018 Jan; 37(4):415-426. PubMed ID: 28967902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4
    Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
    Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-451 limits CD4
    Chapman LM; Ture SK; Field DJ; Morrell CN
    Immunol Res; 2017 Aug; 65(4):828-840. PubMed ID: 28378118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc.
    Tao L; Shu-Ling W; Jing-Bo H; Ying Z; Rong H; Xiang-Qun L; Wen-Jie C; Lin-Fu Z
    Biomed Pharmacother; 2020 May; 125():109962. PubMed ID: 32106373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Examination of the Intestinal Lamina Propria Cellular Compartment of Simian Immunodeficiency Virus-Infected Rhesus Macaques Provides Broader and Deeper Insights into the Link between Aberrant MicroRNA Expression and Persistent Immune Activation.
    Kumar V; Torben W; Kenway CS; Schiro FR; Mohan M
    J Virol; 2016 May; 90(10):5003-5019. PubMed ID: 26937033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
    Wei GY; Hu M; Zhao L; Guo WS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant.
    Zhou Q; Haupt S; Prots I; Thümmler K; Kremmer E; Lipsky PE; Schulze-Koops H; Skapenko A
    J Immunol; 2013 Jun; 190(12):6579-88. PubMed ID: 23650616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer.
    Xu K; Han B; Bai Y; Ma XY; Ji ZN; Xiong Y; Miao SK; Zhang YY; Zhou LM
    Cell Death Dis; 2019 Feb; 10(3):152. PubMed ID: 30770794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of MicroRNA-31 in CD4+ T Cells Contributes to Immunosuppression in Human Sepsis by Promoting TH2 Skewing.
    van der Heide V; Möhnle P; Rink J; Briegel J; Kreth S
    Anesthesiology; 2016 Apr; 124(4):908-22. PubMed ID: 26978146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of T lymphocyte activation by microRNA-21.
    Wang L; He L; Zhang R; Liu X; Ren Y; Liu Z; Zhang X; Cheng W; Hua ZC
    Mol Immunol; 2014 Jun; 59(2):163-71. PubMed ID: 24631982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel microRNA signatures linked to acquired aplastic anemia.
    Hosokawa K; Muranski P; Feng X; Keyvanfar K; Townsley DM; Dumitriu B; Chen J; Kajigaya S; Taylor JG; Hourigan CS; Barrett AJ; Young NS
    Haematologica; 2015 Dec; 100(12):1534-45. PubMed ID: 26354756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
    Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
    Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
    Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
    Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation.
    Liu Y; Nie W; Jin Y; Zhuo A; Zang Y; Xiu Q
    Iran J Immunol; 2016 Jun; 13(2):89-99. PubMed ID: 27350630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.
    Burger ML; Xue L; Sun Y; Kang C; Winoto A
    Blood; 2014 Jun; 123(26):4089-100. PubMed ID: 24735967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell Activation Induces Dynamic Changes in miRNA Expression Patterns in CD4 and CD8 T-cell Subsets.
    Teteloshvili N; Smigielska-Czepiel K; Kroesen BJ; Brouwer E; Kluiver J; Boots AM; van den Berg A
    Microrna; 2015; 4(2):117-22. PubMed ID: 26290349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.